biOasis Provides Scientific Updates on Its Transcend Programs
12. Mai 2015 19:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 12, 2015) - BIOASIS TECHNOLOGIES INC. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering biopharmaceutical company focused on overcoming the...
biOasis European Patent Granted for The Use of Transcend for the Delivery of Enzymes to Treat Lysosomal Storage Disease in The Brain
21. April 2015 17:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 21, 2015) - BIOASIS TECHNOLOGIES INC. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Releases Results From an Ischemic Stroke Model with Transcend BBB Carrier Peptide (MTfp):MTfp-siRNA Reduces Both the Damage Caused by Infarct and Significantly Improves Neurological Score
16. März 2015 09:30 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 16, 2015) - BIOASIS TECHNOLOGIES INC. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Announces Grant of Stock Options
30. Januar 2015 20:30 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 30, 2015) - biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF) (the "Company") wishes to announce that it has granted an aggregate...
biOasis Announces the Release of an Analyst Report
20. Januar 2015 17:24 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 20, 2015) - biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF)(the "Company") wishes to announce the release of an analyst report...
biOasis Engages Willow Tree Group to Assist with Global Business Development Activities
07. Oktober 2014 09:30 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 7, 2014) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF) (TSX VENTURE:BTI), the pioneering biopharmaceutical company focused on the delivery of...
biOasis Initiates MPS II Study with Renowned Lysosomal Storage Disease Expert Dr. Maurizio Scarpa and The Brains for Brain Foundation
18. September 2014 09:30 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 18, 2014) - BIOASIS TECHNOLOGIES INC. (TSX VENTURE:BTI)(OTCQX:BIOAF), the pioneering biopharmaceutical company focused on the delivery of...
biOasis Advances Its Lysosomal Storage Disease Program with a Knockout Model for Sandhoff Disease
09. September 2014 09:30 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 9, 2014) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF)(TSX VENTURE:BTI), announces the commencement of a new phase of its Lysosomal Storage...
biOasis Announces NSERC Grant to the University of British Columbia in Support of Collaborative R&D Work with biOasis
04. September 2014 09:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 4, 2014) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF)(TSX VENTURE:BTI), announces that the Natural Sciences and Engineering Research Council...
biOasis Closes Non-Brokered Private Placement for $1,609,753.15 Gross Proceeds
29. August 2014 17:43 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 29, 2014) - biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF) (the "Company") is please to announce it has closed its non-brokered...